Mode
Text Size
Log in / Sign up

Chronic inflammatory demyelinating polyneuropathy

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for chronic inflammatory demyelinating polyneuropathy

6 trials tracked for chronic inflammatory demyelinating polyneuropathy: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 265 citations.

6Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Phase 2 3 Other / NA 1
  1. Phase 3 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Completed · 265 cited
  2. Phase 3 Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy Completed
  3. Phase 2 Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy Completed
  4. Phase 2 SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Completed
  5. Phase 2 Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy Completed
  6. N/A Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.